Ok the insiders must have known yesterday , no big deal to get approval to do a trial taking several more years.
"OncoPac-1 Study is expected to enrol the first subject in early 2017 and recruitment is anticipated to take approximately 2 years, with each patient to be followed until disease progression. Subjects are then followed for overall survival until death, or until the last enrolled study patient has completed 52 weeks of overall survival follow-up."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.050(4.07%) |
Mkt cap ! $16.78M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $45.65K | 37.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4883 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 7231 | 2 |
View Market Depth
| Last trade - 14.48pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |